Shenzhen Neptunus Interlong Bio-technique Company Limited
HKEX:8329.HK
0.134 (HKD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,064.861 | 986.691 | 838.805 | 1,031.369 | 1,080.871 | 867.123 | 790.286 | 759.111 | 721.346 | 648.268 | 611.666 | 530.458 | 474.652 | 38.256 | 3.696 | 16.31 | 16.16 | 20.181 |
Cost of Revenue
| 617.35 | 542.549 | 464.702 | 457.009 | 437.833 | 364.908 | 365.255 | 371.905 | 368.586 | 371.534 | 360.504 | 334.96 | 309.811 | 25.876 | 2.719 | 7.477 | 5.103 | 7.697 |
Gross Profit
| 447.511 | 444.142 | 374.103 | 574.36 | 643.038 | 502.215 | 425.031 | 387.206 | 352.76 | 276.734 | 251.162 | 195.498 | 164.841 | 12.38 | 0.977 | 8.833 | 11.057 | 12.484 |
Gross Profit Ratio
| 0.42 | 0.45 | 0.446 | 0.557 | 0.595 | 0.579 | 0.538 | 0.51 | 0.489 | 0.427 | 0.411 | 0.369 | 0.347 | 0.324 | 0.264 | 0.542 | 0.684 | 0.619 |
Reseach & Development Expenses
| 46.203 | 28.723 | 25.203 | 20.183 | 27.776 | 27.311 | 29.386 | 18.148 | 37.391 | 35.461 | 33.809 | 30.878 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 90.433 | 93.733 | 80.536 | 64.456 | 65.573 | 55.916 | 51.523 | 50.441 | 58.63 | 53.152 | 59.039 | 48.253 | 48.272 | 37.2 | 25.166 | 13.047 | 17.088 | 12.514 |
Selling & Marketing Expenses
| 252.826 | 244.231 | 238.115 | 420.578 | 456.599 | 349.026 | 262.777 | 225.786 | 199.412 | 116.682 | 101.64 | 75.743 | 63.772 | 7.232 | 1.157 | 3.242 | 3.897 | 11.002 |
SG&A
| 343.259 | 337.964 | 318.651 | 485.034 | 522.172 | 404.942 | 314.3 | 276.227 | 258.042 | 169.834 | 160.679 | 123.996 | 112.044 | 44.432 | 26.323 | 16.289 | 20.985 | 23.516 |
Other Expenses
| 1.067 | 32.312 | 29.193 | 46.469 | 48.907 | 0.924 | 40.854 | 20.666 | 45.22 | 39.384 | 42.613 | 24.309 | 8.984 | -16.87 | 0.467 | 17.584 | 8.923 | 11.888 |
Operating Expenses
| 431.721 | 370.276 | 347.844 | 531.503 | 571.079 | 442.241 | 355.154 | 296.893 | 303.262 | 209.218 | 203.292 | 148.305 | 121.028 | 27.562 | 26.79 | 33.873 | 29.908 | 35.404 |
Operating Income
| 36.248 | 89.293 | 43.706 | 51.042 | 80.238 | 69.431 | 73.557 | 94.555 | 56.635 | 71.459 | 51.252 | 47.193 | 43.813 | -15.182 | -25.813 | -25.04 | -18.851 | -22.92 |
Operating Income Ratio
| 0.034 | 0.09 | 0.052 | 0.049 | 0.074 | 0.08 | 0.093 | 0.125 | 0.079 | 0.11 | 0.084 | 0.089 | 0.092 | -0.397 | -6.984 | -1.535 | -1.167 | -1.136 |
Total Other Income Expenses Net
| -5.574 | -7.032 | -4.596 | -0.83 | -1.417 | -1.787 | -3.229 | -3.886 | -10.361 | -11.078 | -7.684 | -6.59 | -13.876 | -15.33 | -11.663 | -5.831 | -2.541 | -3.018 |
Income Before Tax
| 30.674 | 82.261 | 39.11 | 50.212 | 78.821 | 67.644 | 70.328 | 90.669 | 46.274 | 60.381 | 43.568 | 40.603 | 29.937 | -30.512 | -37.476 | -30.871 | -21.392 | -25.938 |
Income Before Tax Ratio
| 0.029 | 0.083 | 0.047 | 0.049 | 0.073 | 0.078 | 0.089 | 0.119 | 0.064 | 0.093 | 0.071 | 0.077 | 0.063 | -0.798 | -10.14 | -1.893 | -1.324 | -1.285 |
Income Tax Expense
| 16.148 | 18.431 | 4.804 | 11.47 | 15.412 | 16.58 | 14.899 | 17.852 | 14.796 | 15.934 | -3.43 | 4.525 | 13.045 | -0.131 | 11.663 | -0.276 | -0.225 | 0.029 |
Net Income
| 24.127 | 54.346 | 35.958 | 36.592 | 59.719 | 48.089 | 50.257 | 62.692 | 21.055 | 33.174 | 35.855 | 24.298 | 21.686 | -30.104 | -37.476 | -30.595 | -21.167 | -25.967 |
Net Income Ratio
| 0.023 | 0.055 | 0.043 | 0.035 | 0.055 | 0.055 | 0.064 | 0.083 | 0.029 | 0.051 | 0.059 | 0.046 | 0.046 | -0.787 | -10.14 | -1.876 | -1.31 | -1.287 |
EPS
| 0.014 | 0.032 | 0.021 | 0.022 | 0.036 | 0.029 | 0.03 | 0.037 | 0.013 | 0.02 | 0.021 | 0.015 | 0.013 | -0.03 | -0.04 | -0.032 | -0.022 | -0.027 |
EPS Diluted
| 0.014 | 0.032 | 0.021 | 0.022 | 0.036 | 0.029 | 0.03 | 0.037 | 0.013 | 0.02 | 0.021 | 0.015 | 0.013 | -0.03 | -0.04 | -0.032 | -0.022 | -0.027 |
EBITDA
| 56.809 | 124.979 | 75.869 | 78.63 | 103.782 | 88.462 | 91.08 | 112.633 | 77.98 | 94.584 | 72.258 | 67.571 | 68.166 | -5.705 | -15.33 | -18.704 | -11.181 | -16.914 |
EBITDA Ratio
| 0.053 | 0.127 | 0.09 | 0.076 | 0.096 | 0.102 | 0.115 | 0.148 | 0.108 | 0.146 | 0.118 | 0.127 | 0.144 | -0.149 | -4.148 | -1.147 | -0.692 | -0.838 |